Author

J. A. Sandoval

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. G. Madrigal· 1 shared A. Jardim· 1 shared A. N. Michi· 1 shared A. Tomilov· 1 shared E. Siciliani· 1 shared F. Lopes· 1 shared G. Cortopassi· 1 shared G. Fontes· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. G. Madrigal

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 26, 2023

The pharmacopeia of helminth-derived metabolites driving tolerance in dendritic cells

A. N. Michi, N. L. Malacco, J. A. Sandoval…·F. Lopes

The paper identifies helminth-derived metabolites that reprogram dendritic cells to a tolerogenic phenotype, reducing intestinal inflammation in mice.

DOI 10.1101/2023.01.26.525718

mousemetabolomics

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivJun 17, 2020

Novel mTORC1 inhibitors kill Glioblastoma stem cells

J. A. Sandoval, A. Tomilov, S. Datta…·G. Cortopassi

This paper identifies novel mTORC1 inhibitors that effectively kill GBM stem cells and shows their potential as adjuvant therapy when combined with temozolomide.

DOI 10.3390/ph13120419

humanexperimental assay

𝕏 PostBluesky